Cancer-focused biotech firm, Genentech (DNA), priced its IPO at $97, above its original $85-95 range. Trading will begin on Friday.
IPO Pro - "The Ultimate Resource for IPOs"
Don't risk buying another IPO without IPO Pro.
Get your FREE TRIAL now.
